Literature DB >> 10214739

Nonconvulsive status epilepticus of frontal origin.

P Thomas1, B Zifkin, O Migneco, C Lebrun, J Darcourt, F Andermann.   

Abstract

OBJECTIVES: To determine the electroclinical characteristics and causative factors of nonconvulsive status epilepticus (NCSE) of frontal origin.
METHODS: The authors conducted a 5-year prospective study.
RESULTS: Ten patients were studied (seven men, three women; mean age, 56.4 years). Six patients did not have previous epilepsy. The mean diagnostic delay was 48 hours (range, 3 to 96 hours). Two types of frontal NCSE were identified. In type 1 (n = 7), mood disturbances with affective disinhibition or affective indifference were associated with subtle impairment of cognitive functions without overt confusion. EEG showed a unilateral frontal ictal pattern and normal background activity. In type 2 (n = 3), impaired consciousness was associated with bilateral, asymmetric frontal EEG discharges occurring on an abnormal background. Ictal and postictal 99mTc hexamethyl propylene amine oxime (HMPAO) SPECT was performed in five patients and showed unilateral or bilateral frontal HMPAO uptake that aided localization, especially in type 2 NCSE of frontal origin. Etiologies included a focal frontal lesion in six patients (three of which were tumors), neurosyphilis, and nonketotic hyperglycemia. Eight patients did not respond to initial IV benzodiazepine (BZ), but IV phenytoin controlled six patients successfully. The immediate outcome was favorable in all patients. There was no long-term recurrence of SE in seven patients.
CONCLUSIONS: NCSE of frontal origin is a heterogeneous syndrome. Some cases are best described as simple partial NCSE, others as complex partial SE, and there are forms that overlap with absence SE. Emergency EEG and neuropsychological assessment are diagnostic, and SPECT may be useful. Many patients may not respond to IV BZ.

Entities:  

Mesh:

Year:  1999        PMID: 10214739     DOI: 10.1212/wnl.52.6.1174

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Electroencephalography of encephalopathy in patients with endocrine and metabolic disorders.

Authors:  Roland Faigle; Raoul Sutter; Peter W Kaplan
Journal:  J Clin Neurophysiol       Date:  2013-10       Impact factor: 2.177

2.  Diagnosis and Treatment of Nonconvulsive Status Epilepticus in an Intensive Care Unit Setting.

Authors:  Stephan J. Rüegg; Marc A. Dichter
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

3.  Epidemiology, diagnosis, and management of nonconvulsive status epilepticus: Opening Pandora's box.

Authors:  Raoul Sutter; Stephan Rüegg; Peter W Kaplan
Journal:  Neurol Clin Pract       Date:  2012-12

4.  Treatment of nonconvulsive status epilepticus.

Authors:  Trudy Pang; Frank W Drislane
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

5.  Cortical regional hyperperfusion in nonconvulsive status epilepticus measured by dynamic brain perfusion CT.

Authors:  M Hauf; J Slotboom; A Nirkko; F von Bredow; C Ozdoba; R Wiest
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-12       Impact factor: 3.825

Review 6.  Nonconvulsive status epilepticus in adults - insights into the invisible.

Authors:  Raoul Sutter; Saskia Semmlack; Peter W Kaplan
Journal:  Nat Rev Neurol       Date:  2016-04-11       Impact factor: 42.937

Review 7.  Epilepsy, cognition and behavior.

Authors:  Sheffali Gulati; Sangeetha Yoganathan; Biswaroop Chakrabarty
Journal:  Indian J Pediatr       Date:  2014-07-31       Impact factor: 1.967

Review 8.  Non-Convulsive Status Epilepticus in the Presence of Catatonia: A Clinically Focused Review.

Authors:  Dax C Volle; Katharine G Marder; Andrew McKeon; John O Brooks; Jennifer L Kruse
Journal:  Gen Hosp Psychiatry       Date:  2020-11-13       Impact factor: 3.238

9.  Delirium and epilepsy.

Authors:  Peter W Kaplan
Journal:  Dialogues Clin Neurosci       Date:  2003-06       Impact factor: 5.986

10.  Levetiracetam improves disinhibitory behavior in nonconvulsive status epilepticus.

Authors:  Kazuhiko Yamamuro; Hiroki Yoshino; Kentaro Tamura; Toyosaku Ota; Toshifumi Kishimoto
Journal:  Ann Gen Psychiatry       Date:  2014-10-14       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.